StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3030% above fair value
$698.34+15.69 (+2.30%)

Close on Nov 3, 2026Market cap $258.21BP/E 36.9Yield 0.25%

Thermo Fisher Scientific Segment Income — Life Sciences Solutions by Quarter

Segment Income — Life Sciences Solutions ($M)

QuarterlyAnnual

Thermo Fisher Scientific Segment Income — Life Sciences Solutions: $1,022M in Q3 2026, up 5.6% from a year earlier.

Latest, Q3 2026
1,022
Period ended Sep 30, 2026
Change on a year earlier
+5.6%
968 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
7
Documents cited below

Where the Q3 2026 figure comes from

“LSS: Segment income 834 919 968 1,046 3,768 954 1,041 1,022”

Source: Q3 2026 Reconciliation of Financial Information ↗

Full breakdown of external/intersegment revenues, Cost of Revenues, SG&A, R&D, Operating Assets (AR + Inventory), CapEx, and Depreciation under the new ASU 2023-07 accounting standard.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSegment Income — Life Sciences Solutions ($M)Year on yearSource
Q3 2026Sep 30, 20261,022+5.6%Q3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20261,041+13.3%Q3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 2026954+14.4%Q3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20251,046+9.9%Q3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 2025968+14.6%Q3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 2025919+6.2%Q3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 2025834-0.7%Q3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 2024952+6.4%Q4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 2024845-3.1%Q4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 2024865+5.9%Q4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 2024840+0.5%Q4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 2023895-13.9%Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 2023872-16.1%Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 2023817-38.4%Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 2023836-61.6%Q4 & FY2024 Reconciliation of Financial Information ↗
Q4 2022Dec 31, 20221,040–SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗

Breakdown

What makes up segment Income — Life Sciences Solutions

Cite this data

StockData. (2026). Thermo Fisher Scientific Segment Income — Life Sciences Solutions ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg-income-lss

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.

See a number that looks wrong?